Satisfaction with nurse-led telephone follow up for low to intermediate risk prostate cancer patients treated with radical radiotherapy. A comparative study

European Journal of Oncology Nursing

Volumn 17, Issue 2, 2013, Pages 162-169

  Leahy, Mary ^a   Krishnasamy, Meinir ^a   Herschtal, Alan ^a   Bressel, Mathias ^a   Dryden, Tracey ^a   Tai, Keen Hun ^a   Foroudi, Farshad ^a  

^a PETER MACCALLUM CANCER CENTRE   (Australia)

Author keywords

Nurse led services; Patient satisfaction; Prostate cancer; Telephone follow up

Indexed keywords

AFTERCARE; AGED; ARTICLE; COHORT ANALYSIS; COMPARATIVE STUDY; HUMAN; MALE; METHODOLOGY; MIDDLE AGED; NURSING PRACTICE; ORGANIZATION AND MANAGEMENT; PATIENT SATISFACTION; PROSTATE TUMOR; PSYCHOLOGICAL ASPECT; QUESTIONNAIRE; STATISTICAL MODEL; TELEMEDICINE; VERY ELDERLY;

AFTERCARE; AGED; AGED, 80 AND OVER; COHORT STUDIES; HUMANS; LINEAR MODELS; MALE; MIDDLE AGED; NURSE'S PRACTICE PATTERNS; PATIENT SATISFACTION; PROSTATIC NEOPLASMS; QUESTIONNAIRES; TELEMEDICINE;

EID: 84875381766     PISSN: 14623889     EISSN: 15322122     Source Type: Journal    
DOI: 10.1016/j.ejon.2012.04.003     Document Type: Article

References (23)

1. American Cancer Society Cancer Facts and Figures 2010, American Cancer Society, Atlanta.
2. Anderson A. The benefits of nurse led follow up for prostate cancer. British Journal of Nursing 2010, 19(17):1085-1090.
3. Badger T., Segrin C., Figueredo J., Harrington J., Sheppard K., Passalacqua S., et al. Psychosocial interventions to inform quality of life in prostate cancer survivors and their immediate or family partners. Quality of Life Research 2011, 20(6):833-844.
4. Beaver K., Wilson C., Procter J., Sheridan J., Towers G., Heath J., et al. Colorectal cancer follow-up: Patient satisfaction and amenability to telephone after care. European Journal of Oncology Nursing 2011, 15:23-30.
5. Beaver K., Tysver-Robinson D., Campbell M., Twomey M., Williamson S., Hindley A., et al. Comparing hospital & telephone follow up after treatment for breast cancer: randomised equivalence trial. British Medical Journal 2009, 338:a3147.
6. Beaver K., Luker K. Follow-up in breast cancer clinics: reassuring for patients rather than detecting recurrence. PsychoOncology 2005, 14:94-101.
7. Bolla M., Collette L., Blank L., Warde P., Dubois J.B., Mirimanoff R.O., et al. Long-term results with immediate androgen suppression and external irradiation in patients with locally advanced prostate cancer (an EORTC study): a phase III randomised trial. Lancet 2002, 360:103-108.
8. Bryant-Lukosius D., Browne G., diCenso A., Whelan T., Gafni A., Neville A., et al. Evaluating health-related quality of life and priority health probems in patients with prostate cancer: a strategy for defining the role of the advanced practice nurse. Canadian Oncology Nursing Journal 2010, 20(1):5-14.
9. D'Amico A.V., Whittington R., Malkowicz S.B., Cote K., Loffredo M., Schultz D., et al. Biochemical outcome after radical prostatectomy, external beam radiation therapy, or insterstitial radiation therapy for clinically localized prostate cancer. Journal of the American Medical Association 1998, 280:969-974.
10. Haas G., Delongchamps N., Brawley O., Wag G.Y., de la Roza G. The worldwide epidemiology of prostate cancer: perspectives from autopsy studies. Canadian Journal of Urology 2008, 15(1):3866-3871.
11. Hashine K., Kusuhara Y., Miura N., Shirato A., Sumiyoshi Y., Kataoka M. Health-related quality of life using SF-8 and EPIC questionnaires after treatment with radical retropubic prostatectomy and permanent prostate brachytherapy. Japanese Journal of Clinical Oncology 2009, 39(8):502-508.
12. Herr H.W., O'Sullivan M. Quality of life of asymptomatic men with non-metastatic prostate cancer on androgen deprivation therapy. Journal of Urology 2000, 163:1743-1746.
13. Hill J., Bird H., Hopkins R., Lawton C., Wright V. Survey of satisfaction with care in a rheumatology outpatient clinic. Annals of Rheumatic Diseases 1992, 51:195-197.
14. Keating N.L., O'Malley J., Smith M.R. Diabetes and cardiovascular disease during androgen deprivation therapy for prostate cancer. Journal of Clinical Oncology 2006, 24:4448-4456.
15. Kimman M., Bloebaum M., Dirksen C., Houben R., Laubin P., Boersma L. Patient satisfaction with nurse-led telephone follow up after curative treatment for breast cancer. BMC Cancer 2010, 10:174-183.
16. Krishnasamy M., Leahy M., Schubach K., Fraser C., Aranda S. Nurses lead the way in prostate cancer care. Australian Nursing Journal 2007, 14(10):37.
17. Mehnert A., Lehmann C., Graefen M., Huland H., Koch U. Depression, anxiety, post-traumatic stress disorder and health-related quality of life and its association with social support in ambulatory prostate cancer patients. European Journal of Cancer Care 2010, 19(6):736-745.
18. Moore S., Corner J., Haviland J., Wells M., Salmon E., Normand C., et al. Nurse led follow up and conventional medical follow up in the management of patients with lung cancer: a randomised controlled trial. British Medical Journal 2002, 325:1145-1152.
19. Pardo Y., Guedea F., Aguilo F., Fernandez P., Macías V., Marin A., et al. Quality of life impact of primary treatments for localized prostate cancer in patients without hormonal treatment. Journal of Clinical Oncology 2010, 28(31):4687-4696.
20. Roth A.J., Kornblith A.B., Batel-Copel L., Peabody E., Scher H.I., Holland J.C. Rapid screening for psychologic distress in men with prostate carcinoma: a pilot study. Cancer 1998, 82(10):1904-1908.
21. Smith D., Supramaniam R., King M., Ward J., Berry M., Armstrong B.K. Age, health, and education determine supportive care needs of men younger than 70 years with prostate cancer. Journal of Clinical Oncology 2007, 25(18):2560-2566.
22. Steginga S., Occhipinti S., Dunn J., Gardiner R., Heathcote P., Yaxley J. The Supportive care needs of men with prostate cancer. PsychoOncology 2000, 10:66-75.
23. Wei J.T., Dunn R.L., Litwin M.S., Sandler H.M., Sanda M.G. Development and validation of the Expanded Prostate Cancer Index Composite (EPIC) for comprehensive assessment of health- related quality of life in men with prostate cancer. Urology 2000, 56(6):899-905.